Showing 141 - 160 results of 216 for search '"AS Poissy"', query time: 0.12s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150

    Treatment satisfaction and quality of life in patients treated with fingolimod by Mékiès C, Heinzlef O, Jenny B, Ramelli AL, Clavelou P

    Published 2018-05-01
    “…Claude Mékiès,1 Olivier Heinzlef,2 Béatrice Jenny,3 Anne-Laure Ramelli,4 Pierre Clavelou5 1Clinique des Cèdres, Toulouse, 2Neurology Department, CHI Poissy-Saint-Germain-en-Laye, St Germain-en-Laye, 3alSacEP, CHU Strasbourg, Strasbourg, 4Créteil, 5Service de Neurologie, CHU Gabriel Montpied, University of Auvergne, Clermont-Ferrand, France Background: The development of oral treatments for relapsing–remitting multiple sclerosis (RRMS) may alter patient satisfaction and quality of life (QoL). …”
    Get full text
    Article
  11. 151
  12. 152
  13. 153

    Use of Systemic Medications for Treating Adult Atopic Dermatitis in France: Results of a Practice Survey by Fougerousse AC, Jacobzone C, Mery-Bossard L, Reguiai Z, Droitcourt C, Taieb C, Maccari F

    Published 2021-02-01
    “…Anne-Claire Fougerousse,1 Caroline Jacobzone,2 Laure Mery-Bossard,3 Ziad Reguiai,4 Catherine Droitcourt,5 Charles Taieb,6 François Maccari7 On behalf of GEM ResoEczema Group1Dermatology Department, Hôpital d’Instruction des Armées Bégin, Saint Mandé, Val de Marne, France; 2Dermatology Department, Hôpital du Scroff, Groupe Hospitalier Bretagne Sud, Lorient, Morbihan, France; 3Dermatology Department, Centre Hospitalier Intercommunal Poissy Saint Germain en Laye, Saint-Germain-en-Laye, Yvelines, France; 4Dermatology Department, Polyclinique Courlancy, Reims, Marne, France; 5Dermatology Department, Centre Hospitalier Universitaire, Rennes, Ille et Vilaine, France; 6Emma Clinic, Fontenay-sous-Bois, Val de Marne, France; 7Private Practice, Saint-Maur-des-Fossés, Val de Marne, FranceCorrespondence: Anne-Claire FougerousseDermatology Department, Hôpital d’Instruction des Armées Bégin, Saint Mandé, Val de Marne, FranceEmail ac.fougerousse@gmail.comPurpose: Recent studies have illustrated that systemic medications are underused for treating adult atopic dermatitis (AD) and that dermatologists have concerns regarding the safety profile of cyclosporine in AD.Patients and Methods: We performed a national online practice survey between March and April 2020.Results: A total of 305 dermatologists responded, 57% with hospital-based activity and 43% with private practice. …”
    Get full text
    Article
  14. 154

    Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey by Fougerousse AC, Mery-Bossard L, Parier J, Taieb C, Bertolotti A, Maccari F

    Published 2021-04-01
    “…Anne-Claire Fougerousse,1 Laure Mery-Bossard,2 Josiane Parier,3 Charles Taieb,4 Antoine Bertolotti,5,6 Francois Maccari3 On behalf of GEM ResoPso1Dermatology Department, Hôpital d’Instruction des Armées Bégin, Saint Mandé, 94160, France; 2Dermatology Department, Centre Hospitalier Intercommunal Poissy Sant Germain en Laye, Saint-Germain-en-Laye, 78100, France; 3Private Practice, La Varenne Saint Hilaire, Saint-Maur-des-Fossés, 94210, France; 4European Market Maintenance Assessment, Patients Priority Department, Fontenay sous-Bois, France; 5Infectious Diseases and Dermatology Department, Centre Hospitalier Universitaire de la Réunion, Saint Pierre, La Réunion, France; 6Inserm CIC1410, Centre Hospitalier Universitaire de la Réunion, Saint Pierre, La Réunion, FranceCorrespondence: Anne-Claire FougerousseDermatology Department, Hôpital d’Instruction des Armées Bégin, 69 Avenue de Paris, Saint Mandé, 94160, FranceTel + 331 43 98 50 00Fax + 331 43 98 49 15Email ac.fougerousse@gmail.comPurpose: To evaluate the modalities of methotrexate prescription for moderate to severe psoriasis by dermatologists in France.Patients and Methods: We performed a national online practice survey between October and December 2020.Results: A total of 254 dermatologists responded, 237 reported prescribing methotrexate for moderate to severe psoriasis in adults, of which 57% as a first line systemic treatment. …”
    Get full text
    Article
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160